x

Posted 26 January, 2023

GENELUX CORP IPO completed

IPO completed detected for ticker Nasdaq:GNLX in a 424B4 filed on 26 January, 2023.


  This is an initial public offering of shares of common stock of Genelux Corporation.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of GENELUX CORP
Health Care/Life Sciences • Biotechnology
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
Market Cap
$184M
View Company Details